Rare diseases
Investigational molecules
Locations
Back to Poland17 clinical trials in Kedzierzyn-Kozle, Poland. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in PolandBadaniaKliniczne.pl(opens in a new tab)Effect of zenagamtide on major adverse cardiovascular events in overweight or obese adults with established atherosclerotic cardiovascular disease
PolandStudy of Zilebesiran Added to Standard Treatment to Reduce Heart Problems in Adults with High Blood Pressure and Heart Disease Risk
PolandStudy of laroprovstat (AZD0780) to reduce heart attack, stroke and vascular complications in patients with atherosclerotic cardiovascular disease or high risk of developing it
PolandStudy on the Effects of Ferric Carboxymaltose on Heart Health and Quality of Life in Patients with Recent Heart Attack and Iron Deficiency
PolandA study of the safety and efficacy of AC01 in patients with heart failure with reduced ejection fraction
PolandStudy of Zenagamtide (NNC0487-0111) versus placebo in patients with heart failure with preserved or mildly reduced ejection fraction and obesity
PolandStudy on Balcinrenone and Dapagliflozin for Patients with Heart Failure and Kidney Problems
PolandA study to evaluate the effect of olpasiran on major cardiovascular events in patients with atherosclerotic cardiovascular disease and high levels of lipoprotein(a)
PolandStudy of AZD0780 in patients with high cholesterol and heart disease or risk of heart disease to lower bad cholesterol levels
PolandStudy of maridebart cafraglutide to reduce cardiovascular problems in overweight or obese patients with atherosclerotic cardiovascular disease
PolandStudy on the Effects of Pelacarsen on Heart Disease in Patients with Cardiovascular Conditions
PolandA study of ziltivekimab compared to placebo for reducing heart problems in patients who have had a heart attack
PolandThe busiest research cities in the country
What the registry says about research in the country
Groundbreaking research focusing on lipoprotein reduction and innovative therapies for patients with established cardiovascular disease. Studies aim to evaluate new treatments for reducing major cardiovascular events.
Trials utilize advanced therapeutic approaches to improve patient outcomes in cardiovascular care.
Comprehensive studies examining SGLT-2 inhibitors and novel compounds for treating various forms of heart failure, including acute, chronic, and reduced ejection fraction conditions.
Multiple therapeutic approaches are being evaluated to enhance patient care and survival rates.
Innovative research investigating iron deficiency treatment and specialized therapies for patients recovering from myocardial infarction. Studies focus on improving mortality rates and quality of life.
Advanced therapeutic strategies are being tested to optimize recovery outcomes.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
